{
  "pmcid": "2840834",
  "sha256": "a91dfa100cb2eb394c36c30bd8868551fbcbf5dd00919a3fdacbf1205127603f",
  "timestamp_utc": "2025-11-09T22:34:41.677210+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 16.09567972350231,
    "reading_ease": 11.873043394777284,
    "word_count": 217
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Controlled Reoxygenation Cardiopulmonary Bypass in Cyanotic Congenital Heart Defect Repair"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In a single-center, randomised controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "67 cyanotic patients (median age 15 months, interquartile range 6–49 months) undergoing corrective cardiac surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either controlled normoxic (50–0 mm Hg; n = 35) or hyperoxic (150–180 mm Hg; n = 32) cardiopulmonary bypass"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the impact of controlled reoxygenation cardiopulmonary bypass on oxidative stress, inflammatory response, and organ function in children undergoing repair of cyanotic congenital heart defects."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was myocardial damage, measured by troponin I levels, assessed preoperatively and at multiple time points postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "67 cyanotic patients"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Troponin I levels were significantly lower in the normoxic group (−29%, 95% CI −48% to −3%, P = .03)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}